AbbVie vs Uber: Founders, CEOs and History

Company facts

Founders

CEOs and their tenures

Timeline: AbbVie and Uber side by side

1. 2009Uber

   UberCab idea takes shape

   Garrett Camp and Travis Kalanick developed the Uber idea after discussing the difficulty of getting a reliable ride in Paris and San Francisco.

2. 2010Uber

   San Francisco service launch

   Uber launched service in San Francisco in 2010, proving that riders would pay for visible arrival times, stored payment, and digital receipts.

3. 2012Uber

   UberX expands the addressable market

   UberX brought lower-priced rides from personal vehicles into the product mix. That shift moved the company beyond premium black cars, increased driver supply, and opened the larger regulatory debate over licensing, insurance, and worker classification.

4. 2013AbbVie

   AbbVie Launches as an Independent Company

   AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.

5. 2015AbbVie

   Pharmacyclics Acquisition Completed

   AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.

6. 2016Uber

   China exit through Didi deal

   Uber exited China by selling its local operation to Didi Chuxing after an expensive subsidy fight. The retreat showed that local payments, regulation, mapping, and distribution could outweigh global capital and brand recognition.

7. 2017Uber

   Dara Khosrowshahi becomes CEO

   Dara Khosrowshahi replaced Travis Kalanick as CEO after a year of cultural, legal, and regulatory crises. The transition mattered because Uber needed a more credible operating and governance model before entering public markets.

8. 2019AbbVie

   Skyrizi Receives Initial U.S. Approval

   The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.

9. 2019AbbVie

   Rinvoq Receives Initial U.S. Approval

   The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.

10. 2019Uber

    Uber becomes a public company

    Uber completed its initial public offering in May 2019 and later reported roughly $8.0 billion in net IPO proceeds. The listing forced the company to explain its economics to public investors and shifted attention from geographic expansion to profitability.

11. 2020AbbVie

    Allergan Acquisition Completed

    AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.

12. 2020Uber

    Postmates acquisition strengthens U.S. Delivery

    Uber agreed to acquire Postmates for approximately $2.65 billion in an all-stock transaction. The deal added U.S. Delivery density, local merchant relationships, and delivery-as-a-service capabilities as Eats became more important during the pandemic.

13. 2021Uber

    Uber One launches

    Uber One launched as a paid membership connecting rides, delivery, and groceries. The product mattered because it gave frequent users a reason to keep more transactions inside one account instead of switching between single-category rivals.

14. 2021Uber

    Uber Freight agrees to buy Transplace

    Uber Freight agreed to acquire Transplace for approximately $2.25 billion. The deal moved Freight deeper into managed transportation and shipper software, a different business from consumer rides but tied to the same broader logistics ambition.

15. 2023AbbVie

    U.S. Humira Biosimilar Competition Begins

    Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.

16. 2023Uber

    Waymo partnership brings autonomous rides to Uber

    Waymo and Uber announced a multi-year partnership to make the Waymo Driver available through the Uber platform, starting in Phoenix. The deal showed Uber's post-ATG autonomy strategy: partner with vehicle specialists while keeping the marketplace relationship.

17. 2024AbbVie

    ImmunoGen Acquisition Completed

    AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.

18. 2024AbbVie

    Robert A. Michael Becomes CEO

    Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.

19. 2024AbbVie

    Cerevel Therapeutics Acquisition Completed

    AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.

20. 2024Uber

    $44.0 billion revenue year

    FY2024 revenue reached $44.0 billion, up from $37.3 billion in FY2023. The result showed that mobility had recovered after the pandemic while delivery remained a larger and more durable part of the business.

21. 2025AbbVie

    Robert A. Michael Becomes Chairman

    Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.

22. 2025AbbVie

    FY2025 Revenue Reaches $61.160 Billion

    AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.

23. 2025Uber

    $52.0 billion revenue and $193.5 billion gross bookings

    FY2025 revenue reached $52.0 billion, gross bookings reached $193.5 billion, and annual trips rose to 13.6 billion. The milestone mattered because it showed growth alongside GAAP operating income, adjusted EBITDA, and free cash flow at significant scale.

24. 2026AbbVie

    Q1 2026 Revenue Reaches $15.002 Billion

    AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.

25. 2026Uber

    $14.8 billion Delivery Hero offer and 3,300-role restructuring

    Uber offered €41.50 per share for Delivery Hero in July 2026 and launched the tender in September after Delivery Hero's boards backed it. The same month it announced about 3,300 corporate job cuts to remove management layers.

Acquisitions

Questions about AbbVie vs Uber